Extracellular Vesicles from miR-146a Overexpressing Mesenchymal Stem Cells Attenuate Imiquimod-Induced Psoriasis by Regulating Cytokine Expression
Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood. To investigated the effectiveness of extracellular ve...
Uloženo v:
| Vydáno v: | Iranian journal of immunology Ročník 22; číslo 2; s. 119 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Iran
Shiraz Institute for Cancer Research
23.06.2025
|
| Témata: | |
| ISSN: | 1735-1383, 1735-367X, 1735-367X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood.
To investigated the effectiveness of extracellular vesicles (EVs) derived from MSCs that were genetically modified to overexpress miR-146a, in a mouse model of psoriasis.
To enhance miR-146a expression, MSCs were transfected, and their EVs were subsequently purified. Thirty mice were randomly assigned to three groups and induced with imiquimod cream to develop psoriasis-like skin lesions. The treatment groups included: (1) a control group administered PBS, (2) a group treated with EVs containing a control miRNA (miR-control EVs), and (3) a group receiving EVs enriched with miR-146a (miR-146a-EVs). EVs were administered intravenously and lesions were evaluated. Following intravenous administration of EVs, the severity of skin lesions was assessed. Concentrations of key cytokines, including IFN-γ, IL-17, TNF-α, IL-23, IL-6, IL-1β, TGF-β, IL-10, and IL-4, were quantified in both spleen and skin tissue lysates using ELISA and qRT-PCR techniques.
The experimental findings demonstrated that the administration of miR-146a-enriched EVs led to a significant improvement in clinical symptoms. There were substantial reductions observed in combined erythema, scaling, and skin thickness measurements compared to untreated controls. Additionally, levels of proinflammatory cytokines IFN-γ, IL-17, TNF-α, IL-23, IL-6, and IL-1β were significantly downregulated in the miR-146a-EV group, while anti-inflammatory TGF-β, IL-10 and IL-4 were upregulated. The same results were obtained in the spleens of mice.
EVs derived from miR-146a-modified MSCs effectively reduced psoriasis-like inflammation by modulating cytokine expression. This novel cell-free therapy holds promise for the treatment of psoriasis. |
|---|---|
| AbstractList | Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood.
To investigated the effectiveness of extracellular vesicles (EVs) derived from MSCs that were genetically modified to overexpress miR-146a, in a mouse model of psoriasis.
To enhance miR-146a expression, MSCs were transfected, and their EVs were subsequently purified. Thirty mice were randomly assigned to three groups and induced with imiquimod cream to develop psoriasis-like skin lesions. The treatment groups included: (1) a control group administered PBS, (2) a group treated with EVs containing a control miRNA (miR-control EVs), and (3) a group receiving EVs enriched with miR-146a (miR-146a-EVs). EVs were administered intravenously and lesions were evaluated. Following intravenous administration of EVs, the severity of skin lesions was assessed. Concentrations of key cytokines, including IFN-γ, IL-17, TNF-α, IL-23, IL-6, IL-1β, TGF-β, IL-10, and IL-4, were quantified in both spleen and skin tissue lysates using ELISA and qRT-PCR techniques.
The experimental findings demonstrated that the administration of miR-146a-enriched EVs led to a significant improvement in clinical symptoms. There were substantial reductions observed in combined erythema, scaling, and skin thickness measurements compared to untreated controls. Additionally, levels of proinflammatory cytokines IFN-γ, IL-17, TNF-α, IL-23, IL-6, and IL-1β were significantly downregulated in the miR-146a-EV group, while anti-inflammatory TGF-β, IL-10 and IL-4 were upregulated. The same results were obtained in the spleens of mice.
EVs derived from miR-146a-modified MSCs effectively reduced psoriasis-like inflammation by modulating cytokine expression. This novel cell-free therapy holds promise for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood.BackgroundPsoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood.To investigated the effectiveness of extracellular vesicles (EVs) derived from MSCs that were genetically modified to overexpress miR-146a, in a mouse model of psoriasis.ObjectiveTo investigated the effectiveness of extracellular vesicles (EVs) derived from MSCs that were genetically modified to overexpress miR-146a, in a mouse model of psoriasis.To enhance miR-146a expression, MSCs were transfected, and their EVs were subsequently purified. Thirty mice were randomly assigned to three groups and induced with imiquimod cream to develop psoriasis-like skin lesions. The treatment groups included: (1) a control group administered PBS, (2) a group treated with EVs containing a control miRNA (miR-control EVs), and (3) a group receiving EVs enriched with miR-146a (miR-146a-EVs). EVs were administered intravenously and lesions were evaluated. Following intravenous administration of EVs, the severity of skin lesions was assessed. Concentrations of key cytokines, including IFN-γ, IL-17, TNF-α, IL-23, IL-6, IL-1β, TGF-β, IL-10, and IL-4, were quantified in both spleen and skin tissue lysates using ELISA and qRT-PCR techniques.MethodsTo enhance miR-146a expression, MSCs were transfected, and their EVs were subsequently purified. Thirty mice were randomly assigned to three groups and induced with imiquimod cream to develop psoriasis-like skin lesions. The treatment groups included: (1) a control group administered PBS, (2) a group treated with EVs containing a control miRNA (miR-control EVs), and (3) a group receiving EVs enriched with miR-146a (miR-146a-EVs). EVs were administered intravenously and lesions were evaluated. Following intravenous administration of EVs, the severity of skin lesions was assessed. Concentrations of key cytokines, including IFN-γ, IL-17, TNF-α, IL-23, IL-6, IL-1β, TGF-β, IL-10, and IL-4, were quantified in both spleen and skin tissue lysates using ELISA and qRT-PCR techniques.The experimental findings demonstrated that the administration of miR-146a-enriched EVs led to a significant improvement in clinical symptoms. There were substantial reductions observed in combined erythema, scaling, and skin thickness measurements compared to untreated controls. Additionally, levels of proinflammatory cytokines IFN-γ, IL-17, TNF-α, IL-23, IL-6, and IL-1β were significantly downregulated in the miR-146a-EV group, while anti-inflammatory TGF-β, IL-10 and IL-4 were upregulated. The same results were obtained in the spleens of mice.ResultsThe experimental findings demonstrated that the administration of miR-146a-enriched EVs led to a significant improvement in clinical symptoms. There were substantial reductions observed in combined erythema, scaling, and skin thickness measurements compared to untreated controls. Additionally, levels of proinflammatory cytokines IFN-γ, IL-17, TNF-α, IL-23, IL-6, and IL-1β were significantly downregulated in the miR-146a-EV group, while anti-inflammatory TGF-β, IL-10 and IL-4 were upregulated. The same results were obtained in the spleens of mice.EVs derived from miR-146a-modified MSCs effectively reduced psoriasis-like inflammation by modulating cytokine expression. This novel cell-free therapy holds promise for the treatment of psoriasis.ConclusionEVs derived from miR-146a-modified MSCs effectively reduced psoriasis-like inflammation by modulating cytokine expression. This novel cell-free therapy holds promise for the treatment of psoriasis. Background: Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential, yet the specific mechanisms involved are not fully understood. In this study, we investigated the effectiveness of extracellular vesicles (EVs) derived from MSCs that were genetically modified to overexpress miR-146a, in a mouse model of psoriasis. Methods: To enhance miR-146a expression, MSCs were transfected, and their EVs were subsequently purified. Thirty mice were randomly assigned to three groups and induced with imiquimod cream to develop psoriasis-like skin lesions. The treatment groups included: (1) a control group administered PBS, (2) a group treated with EVs containing a control miRNA (miR-control EVs), and (3) a group receiving EVs enriched with miR-146a (miR-146a-EVs). EVs were administered intravenously and lesions were evaluated. Following intravenous administration of EVs, the severity of skin lesions was assessed. Concentrations of key cytokines, including IFN-γ, IL-17, TNF-α, IL-23, IL-6, IL-1β, TGF-β, IL-10, and IL-4, were quantified in both spleen and skin tissue lysates using ELISA and qRT-PCR techniques. Results: The experimental findings demonstrated that the administration of miR-146a-enriched EVs led to a significant improvement in clinical symptoms. There were substantial reductions observed in combined erythema, scaling, and skin thickness measurements compared to untreated controls. Additionally, levels of proinflammatory cytokines IFN-γ, IL-17, TNF-α, IL-23, IL-6, and IL-1β were significantly downregulated in the miR-146a-EV group, while anti-inflammatory TGF-β, IL-10 and IL-4 were upregulated. The same results were obtained in the spleens of mice. Conclusion: EVs derived from miR-146a-modified MSCs effectively reduced psoriasis-like inflammation by modulating cytokine expression. This novel cell-free therapy holds promise for the treatment of psoriasis. |
| Author | Shao, Hongmei Chen, Junjie |
| Author_xml | – sequence: 1 givenname: Hongmei orcidid: 0009-0000-1756-1160 surname: Shao fullname: Shao, Hongmei organization: Department of Dermatology, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu Province, China – sequence: 2 givenname: Junjie orcidid: 0009-0000-7342-4283 surname: Chen fullname: Chen, Junjie organization: Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu Province, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40546034$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkM1OGzEUha0KVP76CFSWuulmUv_PzBJFoUSiCoIIdRd5PHfA6dgOtqciuz4BO16QJ-lETTes7l1895x7zgk68MEDQueUTBgjXHyzazthhMkJJUKWasJqUn9Ax7TksuCq_Hmw3ymv-BE6SWlNiFKEko_oSBAp1ChyjF5nzzlqA30_9Drie0jW9JBwF4PDzt4WVCiNF78hwvMmQkrWP-AfkMCbx63TPb7L4PB0vE_4Imfwg86A3_68zJ19GqwLbTH37WCgxTcpRKuTTbjZ4lt4GA3zTm26zeGX9YBne4fgz9Bhp_sEn_bzFC0vZ8vpVXG9-D6fXlwXGyZoLnTdEamFELKSY3reCK0rKSogirYlq5uSU1GWpm7qqjHEVJJ2nQRDWiMkZfwUff0nu4nhaYCUV86mXRfaQxjSijPGuRr74yP65R26DkP043M7SikppCxH6vOeGhoH7WoTrdNxu_rfN_8LMoOHpQ |
| ContentType | Journal Article |
| Copyright | Copyright Shiraz Institute for Cancer Research 2025 |
| Copyright_xml | – notice: Copyright Shiraz Institute for Cancer Research 2025 |
| DBID | NPM 3V. 7T5 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU CWDGH DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.22034/iji.2025.104576.2909 |
| DatabaseName | PubMed ProQuest Central (Corporate) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College Middle East & Africa Database ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | PubMed ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Middle East & Africa Database Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1735-367X |
| ExternalDocumentID | 40546034 |
| Genre | Journal Article |
| GroupedDBID | --- 53G 5GY 7X7 88E 8FE 8FH 8FI 8FJ 8R4 8R5 ABUWG ACPRK ADBBV AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CWDGH DIK EBD EMOBN EOJEC F5P FRP FYUFA GROUPED_DOAJ HCIFZ HMCUK LK8 M1P M7P NPM OBODZ OK1 PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RNS SV3 UKHRP W2D 3V. 7T5 7U9 7XB 8FK AFFHD AZQEC DWQXO GNUQQ H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-p241t-a9f05a4445859093b4aa8548e061d729b731477c9b98bc0c851ff5ec0dc45123 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001524814900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1735-1383 1735-367X |
| IngestDate | Fri Sep 05 15:49:10 EDT 2025 Sat Nov 01 15:03:20 EDT 2025 Tue Jul 01 05:31:17 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Mesenchymal stem cell Psoriasis Extracellular vesicle Exosome Cytokine |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p241t-a9f05a4445859093b4aa8548e061d729b731477c9b98bc0c851ff5ec0dc45123 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0009-0000-1756-1160 0009-0000-7342-4283 |
| PMID | 40546034 |
| PQID | 3226654557 |
| PQPubID | 105770 |
| ParticipantIDs | proquest_miscellaneous_3223363833 proquest_journals_3226654557 pubmed_primary_40546034 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-06-23 |
| PublicationDateYYYYMMDD | 2025-06-23 |
| PublicationDate_xml | – month: 06 year: 2025 text: 2025-06-23 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | Iran |
| PublicationPlace_xml | – name: Iran – name: Shiraz |
| PublicationTitle | Iranian journal of immunology |
| PublicationTitleAlternate | Iran J Immunol |
| PublicationYear | 2025 |
| Publisher | Shiraz Institute for Cancer Research |
| Publisher_xml | – name: Shiraz Institute for Cancer Research |
| SSID | ssj0066010 |
| Score | 2.3335602 |
| Snippet | Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have... Background: Psoriasis is a chronic inflammatory skin disorder characterized by elevated levels of proinflammatory cytokines. Mesenchymal stem cells (MSCs) have... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 119 |
| SubjectTerms | Cytokines Erythema Extracellular vesicles IL-1β Imiquimod Interleukin 10 Interleukin 17 Interleukin 23 Interleukin 4 Interleukin 6 Intravenous administration Lysates Mesenchymal stem cells miRNA Psoriasis Skin diseases Skin lesions Stem cells Transforming growth factor-b Tumor necrosis factor-α γ-Interferon |
| Title | Extracellular Vesicles from miR-146a Overexpressing Mesenchymal Stem Cells Attenuate Imiquimod-Induced Psoriasis by Regulating Cytokine Expression |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40546034 https://www.proquest.com/docview/3226654557 https://www.proquest.com/docview/3223363833 |
| Volume | 22 |
| WOSCitedRecordID | wos001524814900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1735-367X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066010 issn: 1735-1383 databaseCode: M7P dateStart: 20080301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1735-367X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066010 issn: 1735-1383 databaseCode: 7X7 dateStart: 20080301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Middle East & Africa Database customDbUrl: eissn: 1735-367X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066010 issn: 1735-1383 databaseCode: CWDGH dateStart: 20080301 isFulltext: true titleUrlDefault: https://search.proquest.com/middleeastafrica providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1735-367X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066010 issn: 1735-1383 databaseCode: BENPR dateStart: 20080301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NjtMwELbYXZD2wj9sYamMxNVs6p86PqGl6gokKFVZod4q23F2A2rSbVK0vfEE3HhBnoQZJ4XbXrjkktixxuPxN_bMfIS8EtIazdOM-YHKsah2YC5VloEnFoRDZlgXS-Z_0JNJOp-baXfgVndhlTubGA11Vnk8Iz8BxUOiXKX0m9UVQ9YovF3tKDT2yAFWSRAxdG-6s8RDdDZiQqRQWGtPtBk8nCdCnhRfC_AOucJLTsDcr7lJbkCZcbc5u_e_47xP7nY4k562ivGA3ArlQ3KnZZ7cPiK_xtfN2uKpPYah0i-hjuFxFLNN6LKYMTBtln4CPQ_XbahseUE_YqaSv9wuoePPTVjSEbSv6WkDuHsDmJX-_vHz_bK42sD8ZwxJQXzI6LSG4dm6qKnb0lm4iHxh0Nto21TfAOPScfeHqnxMzs_G56N3rGNoYCvY-RtmTZ4oK6UEpwPkB5NrbQo-UACUkAFsd1oMpNbeOJM6n3iAd3mugk8yD2rAxROyX1ZlOCJU6DDkLpGwZyspdW6MdFyYkA_yoZEy65HjnbgX3SqrF_9k3SMv_76G9YHis2WoNvEbIcDICNEjT9spXazaQh4LAKtyCMrw7ObOn5ND1BQMEOPimOw36014QW77701Rr_tkT891fKZ9cvB2PJnO-lEN_wAdz-Q_ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NctMwENaUFgYu_FMCLYgZ4GbqSPKPDj100pRkmoZOydDePJIst4aJncYO1Lc-ATceg5fiSbprO3DrrQfOtiWN9Gn1rbW7HyFvuVAyYGHsmK6XYFFt6-jQUw54YpZrVIbVdcn8UTAehycn8nCF_F7mwmBY5dIm1oY6zg3-I98C4KFQrucFbQTlvq1-gH9WbA93YTHfMbbXn_QGTish4MzgaCodJRPXU0IIYMUSnHctlAqBpFs4xmLglTrgXREERmoZauMa4B9J4lnjxgbGiUUN2PvZuYMiVXiZ2yp23CJroS9D2FBrvePdj4Ol6ffRu6kzMLmHxf14kzLEmMvFVvo1BXeUeXirCiT_A5PuNbS2Pt72HvxnE_OQ3G95NN1pgP-IrNjsMbnTKGtWT8iv_kU5V3grgWG29Ist6vA_itk0dJoeOWC6Ff0E-9heNKHA2Sk9wEwsc1ZNoeHPpZ3SHnxf0J0S_IoFcHL65_LncJqeLwDfsYOiJ8bG9LCA4akiLaiu6JE9rfXQoLVeVebfgMPTfttDnj0lk5uYpWdkNcsz-5xQHlifaVcAJ_GECBIphWZc2qSb-FKIuEM2lqsbtVakiP4tbYe8-fsY9j9On8psvqjf4RyMKOcdst4gKJo1hUoiIOPCB-y9uL7x1-TuYHIwikbD8f5Lcg9BisFwjG-Q1XK-sJvktvlepsX8VYt3SqIbxtYV6jo8Jw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqLSAuvAsLBYwEx9Cs7Tx8QKjaB121LKtSQW-R7ThtijbZbrLQ3PgF3Pgx_B1-CTN5wK23HjgncRT788w38cx8hLzkQsmAhbFjBl6CTbWto0NPORCJWa5RGVbXLfMPgtksPD6W8w3yq6uFwbTKzibWhjrODf4j3wHgoVCuBwF80qZFzEeTt8tzBxWk8KS1k9NoILJvq28QvhVvpiNY61eMTcZHwz2nVRhwluC5SkfJxPWUEAJIs4TYXgulQuDwFrxcDLRTB3wggsBILUNtXAP0JEk8a9zYwGdgzwOw_puhH3CvRzaHn0fv9jo34GOkU1djcg8b_fGmfIgxl4ud9CyF0JR5eMIKhP81k-4lFLd2dZPb__Ek3SG3Wn5Nd5sNcZds2Oweud4oblb3yc_xRblSeFqB6bf0ky3qtECKVTZ0kR46YNIV_QD72140KcLZCX2PFVrmtFrAwB9Lu6BDeL6guyXEG2vg6vT39x_TRXq-BtzHDoqhGBvTeQGzoYq0oLqih_ak1kmD0YZVmX8Bbk_H7Rvy7AE5uoop2SK9LM_sI0J5YH2mXQFcxRMiSKQUmnFpk0HiSyHiPtnuVjpqrUsR_VvmPnnx9zLYBZw-ldl8Xd_DORhXzvvkYYOmaNk0MImApAsfcPj48sGfkxuAnuhgOtt_Qm4iXjFHjvFt0itXa_uUXDNfy7RYPWuhT0l0xTj6A1oqRN0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extracellular+Vesicles+from+miR-146a+Overexpressing+Mesenchymal+Stem+Cells+Attenuate+%E2%80%8EImiquimod-Induced+Psoriasis+by+Regulating+Cytokine+Expression&rft.jtitle=Iranian+journal+of+immunology&rft.au=Shao%2C+Hongmei&rft.au=Chen%2C+Junjie&rft.date=2025-06-23&rft.pub=Shiraz+Institute+for+Cancer+Research&rft.issn=1735-1383&rft.eissn=1735-367X&rft.volume=22&rft.issue=2&rft.spage=119&rft_id=info:doi/10.22034%2Fiji.2025.104576.2909&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1735-1383&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1735-1383&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1735-1383&client=summon |